Company Momenta Pharmaceuticals, Inc.
Equities
MNTA
US60877T1007
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Lee
PSD | President | - | - |
Patty Eisenhaur
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 19-03-31 | |
Ian D. Fier
PRN | Corporate Officer/Principal | - | 02-09-30 |
Human Resources Officer | - | 07-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20-09-30 | |
Director/Board Member | - | 20-09-30 | |
Jonathan Bryant
BRD | Director/Board Member | - | 20-09-30 |
David Lee
PSD | President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 119,533,224 | 118,124,353 ( 98.82 %) | 568,000 ( 0.4752 %) | 98.82 % |
Company contact information
Momenta Pharmaceuticals, Inc.
1125 Trenton-harbourton Road
08560, Titusville
+617 491 9700
http://www.momentapharma.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |